Common Names
- Gegen-Qinlian Decoction
- Kudzu-Scutellaria-Coptis Decoction
- Coptis Scute and Pueraria Combination
- Pueraria Scutellaria Coptis Decoction
- Galgeunhwanggeumhwangryeon-tang
- Kakkon Ogon Oren To
For Patients & Caregivers
Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.
Ge Gen Huang Qin Huang Lian Tang (GGHQHLT) is a traditional Chinese medicine formula. It’s made up of four herbs.
Ge Gen Huang Qin Huang Lian Tang is used to treat:
- Diarrhea (loose or watery bowel movements)
- Ulcerative colitis (a type of inflammatory bowel disease that causes ulcers in the colon)
- Diabetes mellitus
Talk with your healthcare providers before taking herbal formulas. They can interact with some medications and affect how they work. For more information, read the “What else do I need to know?” section below.
Side effects of GGHQHLT may include:
- Nausea (feeling like you’re going to throw up)
- Vomiting (throwing up)
- Hypoglycemia (when your blood sugar drops to unhealthy level)
For Healthcare Professionals
Ge Gen Huang Qin Huang Lian Tang (GGHQHLT) is a traditional Chinese medicine formula with a history of use as a treatment for diarrhea. Documented in the first century classic text Shang Han Lun (Treatise on Febrile Diseases) during the Han dynasty, GGHQHLT consists of four herbs: Ge Gen (Puerariae Lobatae Radix), Huang Qin (Scutellariae Radix), Huang Lian (Coptidis Rhizoma),and Zhi Gan Cao (Glycyrrhizae Radix et Rhizoma)
Current data indicate effectiveness of GGHQHLT in treating irinotecan-induced diarrhea (1), infectious diarrhea (2), and ulcerative colitis (3), with benefits also seen in pediatric patients with diarrhea (4).
Additional findings suggest this formula may help manage diabetes mellitus (5) (6).
In preclinical studies, combined use of GGHQHLT and anti-mouse PD-1 led to increased expression of interferon gamma, downregulation of PD-1, and increased interleukin-1 levels, all of which help restore T-cell functions (7). GGHQHLT also reduced immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune-checkpoint inhibitor therapy (8).
Larger, well-designed trials are needed to strengthen the evidence base.
- Diarrhea
- Ulcerative Colitis
- Diabetes mellitus
In mice with irinotecan-induced diarrhea, GGHQHLT had a curative effect through various targets that regulated inflammation, oxidative stress, and proliferation (9), along with improving the inhibition of colonic tumor growth (10).
In murine models of ulcerative colitis, GGHQHLT suppressed interleukin-6 / janus kinase 2 / signal transducer and activator of transcription 3 signaling pathway to restore Treg and Th17 cell homeostasis in colonic tissue (11); and repaired the damaged intestinal barrier via regulating gut microbiota-related tryptophan metabolism and restoring production of indole derivatives to activate AhR-mediated IL-22 production (12).
The antidiabetic effects of GGHQHLT are thought to be due to berberine via modulation of gut microbiota (13).
None known.
None reported.